| Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies L Walcher, AK Kistenmacher, H Suo, R Kitte, S Dluczek, A Strauß, ... Frontiers in immunology 11, 1280, 2020 | 788 | 2020 |
| Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches R Diehl, F Ferrara, C Müller, AY Dreyer, DD McLeod, S Fricke, J Boltze Cellular & Molecular Immunology 14 (2), 146-179, 2017 | 160 | 2017 |
| Eight‐color immunophenotyping of T‐, B‐, and NK‐cell subpopulations for characterization of chronic immunodeficiencies A Boldt, S Borte, S Fricke, K Kentouche, F Emmrich, M Borte, ... Cytometry Part B: Clinical Cytometry 86 (3), 191-206, 2014 | 135 | 2014 |
| Potential solutions for manufacture of CAR T cells in cancer immunotherapy U Blache, G Popp, A Dünkel, U Koehl, S Fricke Nature communications 13 (1), 5225, 2022 | 95 | 2022 |
| CAR-expressing natural killer cells for cancer retargeting S Kloess, A Kretschmer, L Stahl, S Fricke, U Koehl Transfusion Medicine and Hemotherapy 46 (1), 4-13, 2019 | 81 | 2019 |
| Advanced flow cytometry assays for immune monitoring of CAR-T cell applications U Blache, R Weiss, A Boldt, M Kapinsky, AR Blaudszun, A Quaiser, ... Frontiers in Immunology 12, 658314, 2021 | 52 | 2021 |
| A real‐time PCR assay for the differentiation of Candida species S Fricke, C Fricke, C Schimmelpfennig, C Oelkrug, U Schönfelder, R Blatz, ... Journal of applied microbiology 109 (4), 1150-1158, 2010 | 51 | 2010 |
| Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation AA Wurm, P Zjablovskaja, M Kardosova, D Gerloff, D Bräuer-Hartmann, ... Nature communications 8 (1), 46, 2017 | 49 | 2017 |
| Detection of immune checkpoint receptors–a current challenge in clinical flow cytometry B Shibru, K Fey, S Fricke, AR Blaudszun, F Fürst, M Weise, S Seiffert, ... Frontiers in immunology 12, 694055, 2021 | 45 | 2021 |
| Accreditation of flow cytometry in Europe U Sack, D Barnett, GY Demirel, C Fossat, S Fricke, N Kafassi, T Nebe, ... Cytometry Part B: Clinical Cytometry 84 (3), 135-142, 2013 | 36 | 2013 |
| Analysis of the tumoricidal and anti-cachectic potential of curcumin C Oelkrug, CM Lange, E Wenzel, S Fricke, M Hartke, J Simasi, A Schubert Anticancer research 34 (9), 4781-4788, 2014 | 35 | 2014 |
| Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering R Kitte, M Rabel, R Geczy, S Park, S Fricke, U Koehl, US Tretbar Molecular Therapy-Methods & Clinical Development 31, 2023 | 32 | 2023 |
| Production and application of CAR T cells: current and future role of Europe V Vucinic, A Quaiser, P Lückemeier, S Fricke, U Platzbecker, U Koehl Frontiers in medicine 8, 713401, 2021 | 32 | 2021 |
| Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo S Przybylski, M Gasch, A Marschner, M Ebert, A Ewe, G Helmig, N Hilger, ... PLoS One 12 (5), e0176517, 2017 | 32 | 2017 |
| CAR T cells for treating autoimmune diseases U Blache, S Tretbar, U Koehl, D Mougiakakos, S Fricke RMD open 9 (4), e002907, 2023 | 27 | 2023 |
| Taking lessons from CAR-T cells and going beyond: tailoring design and signaling for CAR-NK cells in cancer therapy KE Ruppel, S Fricke, U Köhl, D Schmiedel Frontiers in Immunology 13, 822298, 2022 | 26 | 2022 |
| Automated application of low energy electron irradiation enables inactivation of pathogen-and cell-containing liquids in biomedical research and production facilities J Fertey, M Thoma, J Beckmann, L Bayer, J Finkensieper, S Reißhauer, ... Scientific Reports 10 (1), 12786, 2020 | 22 | 2020 |
| Attenuation of graft‐versus‐host‐disease in NOD scid IL‐2Rγ−/− (NSG) mice by ex vivo modulation of human CD4+ T cells N Hilger, J Glaser, C Müller, C Halbich, A Müller, U Schwertassek, ... Cytometry Part A 89 (9), 803-815, 2016 | 20 | 2016 |
| Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment S Fricke, M Ackermann, A Stolzing, C Schimmelpfennig, N Hilger, J Jahns, ... PLoS One 4 (7), e6157, 2009 | 20 | 2009 |
| ABR, a novel inducer of transcription factor C/EBPα, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia CY Namasu, C Katzerke, D Bräuer-Hartmann, AA Wurm, D Gerloff, ... Oncotarget 8 (61), 103626, 2017 | 19 | 2017 |
